Effects and safety of traditional Chinese medicine approaches in cancer symptom care: A systematic review of phase 3 randomized clinical trials.

Researchers reviewed 19 high-quality studies involving over 5,000 cancer patients to see if traditional Chinese medicine could help manage cancer-related symptoms. The studies looked at both hands-on therapies like acupuncture and Tai Chi, as well as herbal medicines, comparing them to standard medical care or placebo treatments. The results showed that acupuncture and Tai Chi were particularly effective for several common problems that cancer patients face. These non-drug approaches significantly reduced pain, fatigue, and trouble sleeping. Acupuncture also helped with dry mouth caused by radiation therapy and hot flashes from hormonal treatments. The evidence for preventing nausea and vomiting from chemotherapy was mixed, with some studies showing benefits and others not, depending on how they were conducted. Chinese herbal medicines showed some promise for preventing mouth sores from treatment, reducing colon polyp recurrence, and helping patients complete their full chemotherapy courses, but the evidence wasn't as strong and more research is needed. Safety information showed that these treatments had similar side effect rates compared to standard care, meaning they appeared safe to use. What this means for you: If you're experiencing pain, fatigue, sleep problems, dry mouth, or hot flashes during cancer treatment, acupuncture or Tai Chi may provide meaningful relief as part of your overall care plan. To get started safely, work with a licensed acupuncturist who has experience treating cancer patients.

This systematic review analyzed 19 phase 3 RCTs (n=5,387 participants, predominantly female with breast, gastrointestinal, and lung cancers) evaluating TCM interventions for cancer-related symptom management. Nonpharmacological modalities—specifically acupuncture and Tai Chi—demonstrated statistically significant benefits for pain, fatigue, insomnia, radiation-induced xerostomia, and hormone therapy-related vasomotor symptoms compared to usual care controls. Evidence for chemotherapy-induced and radiotherapy-induced nausea/vomiting prevention showed heterogeneous results dependent on control arm selection and outcome measurements. Pharmacological TCM interventions yielded inconclusive findings for chemotherapy-induced peripheral neuropathy and hematologic toxicities, though preliminary efficacy was observed for chemoradiotherapy-induced mucositis prophylaxis, colorectal adenoma recurrence reduction, and chemotherapy completion rate enhancement versus placebo/usual care. Adverse event profiles were comparable across intervention and control groups. Clinical takeaway: Strong evidence supports integrating acupuncture and Tai Chi into supportive oncology care protocols; pharmacological TCM modalities require additional rigorous, multicenter investigation with standardized safety monitoring.